Cargando…

Investigation of the association between metabolic syndrome and breast cancer patients

One of the most serious cancers among women is breast cancer. This disease is the first reason for the death of women due to cancer. Increasing breast cancer risk may associate with many factors including genetic, reproductive factors, people's lifestyle, metabolic syndrome (MS) and hormones. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Eskandari, Delaram, Khodabandehloo, Niloofar, Gholami, Abbas, Samadanifard, Hosein, Hejrati, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254422/
https://www.ncbi.nlm.nih.gov/pubmed/32499883
http://dx.doi.org/10.4081/ejtm.2019.8776
_version_ 1783539542305800192
author Eskandari, Delaram
Khodabandehloo, Niloofar
Gholami, Abbas
Samadanifard, Hosein
Hejrati, Alireza
author_facet Eskandari, Delaram
Khodabandehloo, Niloofar
Gholami, Abbas
Samadanifard, Hosein
Hejrati, Alireza
author_sort Eskandari, Delaram
collection PubMed
description One of the most serious cancers among women is breast cancer. This disease is the first reason for the death of women due to cancer. Increasing breast cancer risk may associate with many factors including genetic, reproductive factors, people's lifestyle, metabolic syndrome (MS) and hormones. MS has been known as a risk factor for prostate, pancreatic, breast and colorectal cancers. The purpose of this review is to identify the relationship between MS components and breast cancer individually. This study was performed by researching electronic database references including PubMed, Google Scholar, CINAHL ProQuest, and web of science through 2019. The effect of MS with its components and breast cancer was reported in many studies. Nevertheless, a thorough understanding of the mechanisms involved remains a challenge. However, one can take several preventive measures, including a proper diet, which is one of the most important determinants of metabolic status. Also, general preventive recommendations are including reducing alcohol consumption, red meat and total fat in the diet. Moreover, increasing the consumption of vegetable and fruit reduce the proportion of MS patients to improve the outcome of breast cancer patients.
format Online
Article
Text
id pubmed-7254422
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-72544222020-06-03 Investigation of the association between metabolic syndrome and breast cancer patients Eskandari, Delaram Khodabandehloo, Niloofar Gholami, Abbas Samadanifard, Hosein Hejrati, Alireza Eur J Transl Myol Article One of the most serious cancers among women is breast cancer. This disease is the first reason for the death of women due to cancer. Increasing breast cancer risk may associate with many factors including genetic, reproductive factors, people's lifestyle, metabolic syndrome (MS) and hormones. MS has been known as a risk factor for prostate, pancreatic, breast and colorectal cancers. The purpose of this review is to identify the relationship between MS components and breast cancer individually. This study was performed by researching electronic database references including PubMed, Google Scholar, CINAHL ProQuest, and web of science through 2019. The effect of MS with its components and breast cancer was reported in many studies. Nevertheless, a thorough understanding of the mechanisms involved remains a challenge. However, one can take several preventive measures, including a proper diet, which is one of the most important determinants of metabolic status. Also, general preventive recommendations are including reducing alcohol consumption, red meat and total fat in the diet. Moreover, increasing the consumption of vegetable and fruit reduce the proportion of MS patients to improve the outcome of breast cancer patients. PAGEPress Publications, Pavia, Italy 2020-04-01 /pmc/articles/PMC7254422/ /pubmed/32499883 http://dx.doi.org/10.4081/ejtm.2019.8776 Text en http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Eskandari, Delaram
Khodabandehloo, Niloofar
Gholami, Abbas
Samadanifard, Hosein
Hejrati, Alireza
Investigation of the association between metabolic syndrome and breast cancer patients
title Investigation of the association between metabolic syndrome and breast cancer patients
title_full Investigation of the association between metabolic syndrome and breast cancer patients
title_fullStr Investigation of the association between metabolic syndrome and breast cancer patients
title_full_unstemmed Investigation of the association between metabolic syndrome and breast cancer patients
title_short Investigation of the association between metabolic syndrome and breast cancer patients
title_sort investigation of the association between metabolic syndrome and breast cancer patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254422/
https://www.ncbi.nlm.nih.gov/pubmed/32499883
http://dx.doi.org/10.4081/ejtm.2019.8776
work_keys_str_mv AT eskandaridelaram investigationoftheassociationbetweenmetabolicsyndromeandbreastcancerpatients
AT khodabandehlooniloofar investigationoftheassociationbetweenmetabolicsyndromeandbreastcancerpatients
AT gholamiabbas investigationoftheassociationbetweenmetabolicsyndromeandbreastcancerpatients
AT samadanifardhosein investigationoftheassociationbetweenmetabolicsyndromeandbreastcancerpatients
AT hejratialireza investigationoftheassociationbetweenmetabolicsyndromeandbreastcancerpatients